New Delhi, 20 November 2026: New research from AIG Hospitals makes a strong case for adopting diagnostic procedures that combine clinical suitability with lower costs and a smaller environmental footprint. Led by Dr Hardik Rughwani, the EVERGREEN-IBD study, published in the prestigious journal “Alimentary Pharmacology & Therapeutics,” found that intestinal ultrasound had the lowest carbon emissions and hospital cost among the imaging tests assessed for inflammatory bowel disease (IBD) care. The findings support its wider adoption for follow-up monitoring where clinically appropriate.
IBD, which includes Crohn’s Disease (CD) and Ulcerative Colitis (UC), often requires repeated investigations over a lifetime. Each examination carries a financial and environmental cost throughelectricity consumption, equipment use, consumables and waste. With healthcare contributing an estimated 4.4–5% of global greenhouse gas emissions, choosing less resource-intensive modalities with appropriate clinical utility presents an opportunity to makehealthcare more sustainable.
Conducted at AIG Hospitals during December 2025, the study compared the operational carbon footprint of laboratory tests, colonoscopy and enteroscopy, CT, MRI and intestinal ultrasound using acommon assessment framework. Estimated emissions per procedure were 0.85 kg of carbon dioxide equivalent for intestinal ultrasound, compared with 3.87 kg for colonoscopy/enteroscopy, 5.82 kg for CT and 21.25 kg for MRI. Intestinal ultrasound’s estimated footprintwas therefore approximately 96% lower than MRI’s per examination in this study.
The cost comparison reinforced the environmental findings. At AIG, the hospital cost of intestinal ultrasound was approximately half that of colonoscopy and one-sixth that of MR enterography,a specialised MRI examination of the bowel.
Dr D Nageshwar Reddy, Chairman, AIG Hospitals, said “The future of healthcare must bring together clinical excellence, affordability and environmental responsibility. For chronic diseases, patients need care over many years, the choices we make repeatedly can have a substantial cumulative impact. When a lessresource-intensive investigation can reliably answer the clinical question, its use deserves serious consideration. Sustainability should be built into how we deliver care along with patient safety and clinical need.”
Intestinal ultrasound uses a probe moved over the abdomen to assess bowel inflammation. It involves no ionizing radiation and ordinarily requires neither sedation nor bowel-cleansing preparation.It can be performed during a clinic visit, providing information that helps clinicians assess disease activity and treatment response. Its role in IBD monitoring is supported by existing clinical guidance.